Lactobacillus-dominated Cervicovaginal Microbiota Associated with Reduced HIV/STI Prevalence and Genital HIV Viral Load in African Women
Overview
Microbiology
Authors
Affiliations
Cervicovaginal microbiota not dominated by lactobacilli may facilitate transmission of HIV and other sexually transmitted infections (STIs), as well as miscarriages, preterm births and sepsis in pregnant women. However, little is known about the exact nature of the microbiological changes that cause these adverse outcomes. In this study, cervical samples of 174 Rwandan female sex workers were analyzed cross-sectionally using a phylogenetic microarray. Furthermore, HIV-1 RNA concentrations were measured in cervicovaginal lavages of 58 HIV-positive women among them. We identified six microbiome clusters, representing a gradient from low semi-quantitative abundance and diversity dominated by Lactobacillus crispatus (cluster R-I, with R denoting 'Rwanda') and L. iners (R-II) to intermediate (R-V) and high abundance and diversity (R-III, R-IV and R-VI) dominated by a mixture of anaerobes, including Gardnerella, Atopobium and Prevotella species. Women in cluster R-I were less likely to have HIV (P=0.03), herpes simplex virus type 2 (HSV-2; P<0.01), and high-risk human papillomavirus (HPV; P<0.01) and had no bacterial STIs (P=0.15). Statistically significant trends in prevalence of viral STIs were found from low prevalence in cluster R-I, to higher prevalence in clusters R-II and R-V, and highest prevalence in clusters R-III/R-IV/R-VI. Furthermore, only 10% of HIV-positive women in clusters R-I/R-II, compared with 40% in cluster R-V, and 42% in clusters R-III/R-IV/R-VI had detectable cervicovaginal HIV-1 RNA (Ptrend=0.03). We conclude that L. crispatus-dominated, and to a lesser extent L. iners-dominated, cervicovaginal microbiota are associated with a lower prevalence of HIV/STIs and a lower likelihood of genital HIV-1 RNA shedding.
van Smoorenburg M, Remmerswaal E, Segui-Perez C, van Hamme J, Strijbis K, Geijtenbeek T Eur J Immunol. 2025; 55(3):e202451192.
PMID: 40071689 PMC: 11898549. DOI: 10.1002/eji.202451192.
The role of pharmacomicrobiomics in HIV prevention, treatment, and women's health.
Swanson E, Basting C, Klatt N Microbiome. 2024; 12(1):254.
PMID: 39627860 PMC: 11613800. DOI: 10.1186/s40168-024-01953-3.
Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections.
Avitabile E, Menotti L, Croatti V, Giordani B, Parolin C, Vitali B Int J Mol Sci. 2024; 25(17).
PMID: 39273118 PMC: 11395631. DOI: 10.3390/ijms25179168.
van Teijlingen N, van Smoorenburg M, Sarrami-Forooshani R, Zijlstra-Willems E, van Hamme J, Borgdorff H J Infect Dis. 2024; 230(1):e43-e47.
PMID: 39052703 PMC: 11272099. DOI: 10.1093/infdis/jiae166.
Kaelin E, Mitchell C, Soria J, La Rosa A, Ticona E, Coombs R Res Sq. 2024; .
PMID: 38699319 PMC: 11065064. DOI: 10.21203/rs.3.rs-4078561/v1.